![BREVAGen reclassified 64 percent of above average Gail risk subjects](http://www.globenewswire.com/de/Attachment/LogoDisplay/268032?filename=268032.png&size=2)
PEARL W. YEE, M.D. INC. OF SAN FRANCISCO ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
16. September 2013 10:08 ET
|
Genetic Technologies Group
SAN FRANCISCO, Sept. 16, 2013 (GLOBE NEWSWIRE) -- Pearl Yee, MD, FACOG and clinical professor at the University of California, San Francisco, is pleased to announce that her private practice, Pearl W....
![BREVAGen Logo_edit](http://www.globenewswire.com/de/Attachment/LogoDisplay/265814?filename=265814.jpg&size=2)
OB/GYN ASSOCIATES IN LEWISBURG, PA ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
26. August 2013 13:06 ET
|
Genetic Technologies Group
SUNBURY, PA., Aug. 26, 2013 (GLOBE NEWSWIRE) -- Russell Stankiewicz, MD, FACOG, CCD, NMCP, is pleased to announce that OB/GYN Associates of Lewisburg, P.C. in Lewisburg, PA is now offering the...
![BREVAGen_reclassified](http://www.globenewswire.com/de/Attachment/LogoDisplay/259900?filename=259900.jpg&size=2)
THE HEWITT CENTER FOR BREAST WELLNESS AT GRIFFIN HOSPITAL IN DERBY, CT LAUNCHES HIGH-RISK PROGRAM INCLUDING STATE-OF-THE-ART BREAST CANCER SCREENING OPTIONS
24. Juni 2013 12:16 ET
|
Genetic Technologies Group
DERBY, Conn., June 24, 2013 (GLOBE NEWSWIRE) -- Denise Barajas, MD, medical director at The Hewitt Center for Breast Wellness in Derby, CT, has launched a high-risk breast cancer program that includes...
![BREVAGen chart](http://www.globenewswire.com/de/Attachment/LogoDisplay/250915?filename=250915.jpg&size=2)
STUDY VALIDATES BREVAGen MORE ACCURATELY IDENTIFIES BREAST CANCER RISK LEADING TO INCREASED BREAST HEALTH COMPLIANCE
15. April 2013 12:06 ET
|
Genetic Technologies Group
CHARLOTTE, N.C., April 15, 2013 (GLOBE NEWSWIRE) -- Phenogen Sciences, Inc. recently presented study results demonstrating that BREVAGen™, a first-in-class, scientifically-validated predictive...
![BREVAGen chart](http://www.globenewswire.com/de/Attachment/LogoDisplay/246834?filename=246834.jpg&size=2)
The Centers for Women's Health in Stamford CT Pioneers Breast Cancer Risk Assessment
18. März 2013 12:14 ET
|
Genetic Technologies Group
STAMFORD, Conn., March 18, 2013 (GLOBE NEWSWIRE) -- Dr. Joel Evans, Founder and Director of The Center for Women's Health, is one of the first physicians in the nation to make the BREVAGen™...
![brevagen-box](http://www.globenewswire.com/de/Attachment/LogoDisplay/238963?filename=238963.jpg&size=2)
Noble Hospital Comprehensive Breast Program in Massachusetts Pioneers Breast Cancer Risk Assessment
14. Januar 2013 10:15 ET
|
Noble Hospital
SPRINGFIELD, Mass., Jan. 14, 2013 (GLOBE NEWSWIRE) -- Dr. Steven Schonholz, Director of the Comprehensive Breast Program at Noble Hospital, is one of the first physicians in the nation to make the...
![BREVAGen Logo](http://www.globenewswire.com/de/Attachment/LogoDisplay/227762?filename=227762.jpg&size=2)
Primary Care Associates of Bellevue Pioneers Breast Cancer Risk Assessment
24. September 2012 12:16 ET
|
Primary Care Associates P.S.
BELLEVUE, WASH., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Dr. Lisa Steffensen of Primary Care Associates is one of the first physicians in the nation to make the BREVAGen™ predictive risk test...